David Kirn

David Kirn

Founder at 4D MOLECULAR THERAPEUTICS, INC.

Net worth: 34 M $ as of 2024-03-30

62 year
Health Technology
Consumer Services
Commercial Services

Profile

David H.
Kirn
was the founder of SillaJen Biotherapeutics, Inc. (founded in 2006) and 4D Molecular Therapeutics, Inc. (founded in 2013), where he holds the titles of President & Chief Medical Officer and Chief Executive Officer & Director, respectively.
Dr. Kirn is also the founder of Ignite Immunotherapy, Inc. Dr. Kirn's current jobs include Director at Coagulant Therapeutics, Inc. and Professor at the University of Oxford.
Dr. Kirn's former jobs include Principal at Warner-Lambert Co., Principal at Onyx Pharmaceuticals, Inc., Member at Harvard University, Faculty Member at The University of California, San Francisco, Advisor at National Institutes of Health, Principal at IP2IPO Innovations Ltd., and Faculty Member at Specialist Diabetes Research & Treatment Centre LLC.
Dr. Kirn obtained his undergraduate degree from the University of California, Berkeley in 1985 and his doctorate degree from The University of California, San Francisco in 1989.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-02-07 1,059,153 ( 2.13% ) 34 M $ 2024-03-30

David Kirn active positions

CompaniesPositionStart
4D MOLECULAR THERAPEUTICS, INC. Founder 2013-09-11
University of Oxford Corporate Officer/Principal -
Director/Board Member -
All active positions of David Kirn

Former positions of David Kirn

CompaniesPositionEnd
Founder 2018-12-31
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
The University of California, San Francisco Corporate Officer/Principal -
See the detail of David Kirn's experience

Training of David Kirn

University of California, Berkeley Undergraduate Degree
The University of California, San Francisco Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Kirn's experience

Connections

100 +

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies9

Health Technology

Health Technology

Commercial Services

Government

Commercial Services

Health Services

4D Molecular Therapeutics, Inc.

Health Technology

Health Technology

See company connections